Recent interventional evidence also demonstrates that LDL-C lowering therapies, such as those interfering with PCSK9 mRNA expression, can improve vascular stiffness [62], suggesting that lipidomic remodeling associated with atherosclerosis may be reversible. The gene discussed is PCSK9; the disease is atherosclerosis.